magnet in Biological Products
Navigation Links
magnet in Biological Products
MagCellect Magnet from R&D Systems
Description: All MagCellect Ferrofluid products perform optimally when used in conjunction with R&D Systems MagCellect Magnet. To accommodate different processing capacities, this neodymium iron boron permanent magnet holds either six 12 x 75 mm test tubes or two 15 x 100 mm test tubes....Company:R&D Systems
Blue Magnet from StemCell Technologies, Inc.
Description: This device is designed to run four simultaneous separations with the following StemSep ; column sizes: 0.3in., 0.5in., and 0.6in.. Depending on the column size, a range of 2x10 7 - 1.5 x 10 9 cells can be loaded per column. This...Company:StemCell Technologies, Inc.
Agencourt SPRPlate 96R - Ring Magnet Plate from Agencourt Bioscience
Description: Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....Company:Agencourt Bioscience
Agencourt SPRPlate 384 Magnet Plate from Agencourt Bioscience
Description: Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....Company:Agencourt Bioscience
Agencourt SPRPlate D - Disc Magnet Plate from Agencourt Bioscience
Description: Designed for use with the Agencourt SprintPrep 384 kit and all MCPrep reagent kits. Used with flat bottom 96-well microplates such as deep well plates used to culture bacteria....Company:Agencourt Bioscience
MATra-si Reagent for 200g nucleic acids from IBA GmbH
Description:...nt transfection. MATra-si Reagent can be used for adherent cells; for suspension cells see MATra-S Immobilizer. For the transfection process a special magnet plate is required, which is also available at IBA GmbH....Company:IBA GmbH
StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
Description:... This complete kit contains enough separation reagents to perform separations from a total of 5 x 10 8 cells, and includes the StemSep red magnet and all the necessary reagents and buffers for the specific cell type to be enriched, including the StemSep red magnet....Company:StemCell Technologies, Inc.
Other TagsEmphasizeEdwardsNSCNSCNSCNSCNSCEthosSafetSafetSafetSafetSafetSafetOther Contentssmearsmearsmearsmearperitonitispersonalitypersonalitypersonalitypersonalitypertussispertussisperitonsillarpersonalpersonalpersonalpersonalpersonalpersonalpersonalpersonalpersonalpesticidespesticidespesticidespesticidespernicious
OlivesEmphasizeAugmentsWaterAidGlucocorticoidsTumorousDyscalculiaEdwardsElizabethNSCEvilsEthosTCMSafet
(Date:12/4/2009)... German . , A new study of the ... understand the positive effect of dietary restriction on healthy ageing. ... shown that dietary restriction increases longevity, but with a potential ... fly reproduces less frequently with a reduced litter size on ...
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), a ... identification solutions, announced that a majority of its ... approved the sale of the company,s Law Enforcement ... shares voted, 98.6% were cast in favor and ...
(Date:12/3/2009)... The extinction of plant and animal species can be likened ... cabinet full of potential medicines into the trash, or replacing ... of species and their habitats may not just make the ... you at greater risk for catching some nasty disease. , ...
Breaking Biology News(10 mins):How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Species down, disease up 2Species down, disease up 3Species down, disease up 4Dr Drew and Drug Czar Host Online Chat 57362 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 1Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 2Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 3Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 4(Date:12/7/2009)... Consolidated Access to Interdisciplinary Evidence-based Content throughout the Clinical ... ... (PRWEB) December 7, 2009 -- Institutions currently using point-of-care ... Zynx Health will benefit from a new ... evidence-based resources, resulting in quicker retrieval of relevant and ...
(Date:12/7/2009)... free tax calculator. Answer simple questions about income and watch the tax ... ... return by using the free tax calculator. , , , , ,The calculator ... or worrying about how much the return will be or how much tax ... Find out right now with a few clicks of the mouse. , ...
(Date:12/7/2009)... Dec. 7 Cell Therapeutics, Inc. ("CTI") ... Pettengell, M.D. of St. George,s Hospital, University of ... Society of Hematology ("ASH") Annual Meeting updated results ... clinical trial of pixantrone (the "PIX 301 EXTEND ... ("NHL") patients who have failed 2 or ...
(Date:12/7/2009)... be able to reverse some of the damage to ... down their cigarettes, according to research out of the ... research is published in the December 15 issue of ... and Critical Care Medicine . , "We found that ... of the epithelium, or lining, of the airways in ...
(Date:12/6/2009)... Antonio Bay ,, SILVER SPRING, Md., Dec. 6 ... advising consumers to avoid eating oysters harvested from the ... to reports of norovirus-associated illnesses in some people who ... located on the Gulf of Texas. ,, (Logo: ... with the Centers for Disease Control and Prevention (CDC) ...
Breaking Medicine News(10 mins):Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:2009 Free Tax Return Calculator 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2[1] EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content [1] 2009 Free Tax Return Calculator [0] Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data[0] Quitting smoking can reverse asthma-inducing changes in lungs[0] FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |